Sangamo (SGMO) Posts Wider than Expected Q1 Loss
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
EPS Growth %: +25.0%
Financial Fact:
Collaboration agreements: 2.73M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: +25.0%
Financial Fact:
Collaboration agreements: 2.73M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Sangamo Biosciences Inc. (Nasdaq: SGMO) reported Q1 loss of $0.21, $0.04 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $4.09 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Vince Holding (VNCE) Tops Q1 EPS by 21c
- John Wiley & Sons, Inc. (WLY) Tops Q4 EPS by 12c; offers outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
